Related references
Note: Only part of the references are listed.A multicenter analysis of genomic profiles and PD-L1 expression of primary lymphoepithelioma-like carcinoma of the lung
Zhanhong Xie et al.
MODERN PATHOLOGY (2020)
Neoadjuvant PD-1 inhibitor (Sintilimab) in NSCLC
Shugeng Gao et al.
JOURNAL OF THORACIC ONCOLOGY (2020)
Primary pulmonary lymphoepithelioma-like carcinoma
Ying Fan et al.
MEDICAL ONCOLOGY (2020)
Effect of anlotinib as a third- or further-line therapy in advanced non-small cell lung cancer patients with different histologic types: Subgroup analysis in the ALTER0303 trial
Ying Cheng et al.
CANCER MEDICINE (2020)
Phage display-identified PD-L1-binding peptides reinvigorate T-cell activity and inhibit tumor progression
Smriti Gurung et al.
BIOMATERIALS (2020)
Pulmonary Lymphoepithelioma-like Carcinoma
Sakda Sathirareuangchai et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2019)
Outcomes to first-line pembrolizumab in patients with non-small-cell lung cancer and very high PD-L1 expression
E. J. Aguilar et al.
ANNALS OF ONCOLOGY (2019)
First-line platinum-based chemotherapy and survival outcomes in locally advanced or metastatic pulmonary lymphoepithelioma-like carcinoma
Zuan Lin et al.
LUNG CANCER (2019)
Primary Pulmonary Lymphoepithelioma-Like Carcinoma Response Favorably To Nivolumab: A Case Report
Zhi-Xin Qiu et al.
ONCOTARGETS AND THERAPY (2019)
EBV-positive Primary Pulmonary Lymphoepithelioma-like Carcinoma Response to PD-L1 Blockade
Anand Narayanan et al.
CLINICAL LUNG CANCER (2019)
Thorough survey and analysis of pulmonary lymphoepithelioma-like carcinoma in Macau and multimodality treatment for advanced disease
Na Zhou et al.
LUNG CANCER (2019)
Cytology cell blocks are suitable for immunohistochemical testing for PD-L1 in lung cancer
H. Wang et al.
ANNALS OF ONCOLOGY (2018)
Prognosis and distribution of lymph nodes metastases in resectable primary pulmonary lymphoepithelioma-like carcinoma: A large cohort from a single center
Xiangyang Yu et al.
THORACIC CANCER (2018)
Pembrolizumab plus Chemotherapy for Squamous Non-Small-Cell Lung Cancer
L. Paz-Ares et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Response of advanced stage recurrent lymphoepithelioma-like carcinoma to nivolumab
Vivek Kumar et al.
IMMUNOTHERAPY (2017)
Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer
Martin Reck et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Metastatic lymphoepithelioma-like carcinoma of the lung treated with nivolumab: a case report and focused review of literature
Chul Kim et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2016)
Introduction to The 2015 World Health Organization Classification of Tumors of the Lung, Pleura, Thymus, and Heart
William D. Travis et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
PD-L1 is highly expressed in lung lymphoepithelioma-like carcinoma: A potential rationale for immunotherapy
Yih-Leong Chang et al.
LUNG CANCER (2015)
Positive expression of programmed death ligand-1 correlates with superior outcomes and might be a therapeutic target in primary pulmonary lymphoepithelioma-like carcinoma
Li Jiang et al.
ONCOTARGETS AND THERAPY (2015)
Computed tomography characteristics of primary pulmonary lymphoepithelioma-like carcinoma in 41 patients
Huali Ma et al.
EUROPEAN JOURNAL OF RADIOLOGY (2013)
Multimodality Treatment and Long-Term Follow-Up of the Primary Pulmonary Lymphoepithelioma-Like Carcinoma
Chung-Jen Huang et al.
CLINICAL LUNG CANCER (2012)
Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer
Suzanne L. Topalian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
Lung Adjuvant Cisplatin Evaluation: A pooled analysis by the LACE collaborative group
Jean-Pierre Pignon et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
The IASLC lung cancer staging project: Proposals for the revision of he TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours
Peter Goldstraw et al.
JOURNAL OF THORACIC ONCOLOGY (2007)
Adjuvant chemotherapy for non-small cell lung cancer: Contribution of the International Adjuvant Lung Trial
A Dunant et al.
CLINICAL CANCER RESEARCH (2005)
Relationship between Epstein-Barr virus and lymphoepithelioma-like carcinoma of the lung: A clinicopathologic study of 6 cases and review of the literature
CY Castro et al.
HUMAN PATHOLOGY (2001)
Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation
GJ Freeman et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Association of Epstein-Barr virus with lymphoepithelioma-like carcinoma of the lung in southern China
AJ Han et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2000)
Share Paper
